Anticancer antibody drug conjugate (MBrace Therapeutics)

N/A

Report date: 2023/10/09 10:03:23

Base Information

Drug NameAnticancer antibody drug conjugate (MBrace Therapeutics)
Drug Alias NameADC-2ADC2
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMBrace Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMBrace Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A